Written by LAURAN NEERGAARD

Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the U.S.

With global vaccine supplies still tight, much of the world is struggling to vaccinate adults in the quest to end the pandemic. But earlier this month, the U.S. and Canada authorized another vaccine — the shot made by Pfizer and BioNTech — to be used starting at age 12.

Moderna aims to be next in line, saying it will submit its teen data to the U.S. Food and Drug Administration and other global regulators early next month.

The company studied more than 3,700 12- to 17-year-olds. Preliminary findings showed the vaccine triggered the same signs of immune protection in kids as it does in adults, and the same kind of temporary side effects such as sore arms, headache and fatigue.

There were no COVID-19 diagnoses in those given two doses of the Moderna vaccine compared with four cases among kids given dummy shots. In a press release, the company also said the vaccine appeared 93% effective two weeks after the first dose.

While children are far less likely than adults to get seriously ill from COVID-19, they represent about 14% of the nation’s coronavirus cases. At least 316 have died in the U.S. alone, according to a tally by the American Academy of Pediatrics.

With plenty of vaccine supply in the U.S., younger teens flocked to get Pfizer’s shot in the days after FDA opened it to them, part of a push to get as many kids vaccinated as possible before the next school year.

Both Pfizer and Moderna have begun testing in even younger children, from age 11 down to 6-month-old babies. This testing is more complex: Teens receive the same dose as adults, but researchers are testing smaller doses in younger children. Experts hope to see some results in the fall.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

 

Photo via AP Photo/Hans Pennink.

 

Related Stories
‹
Moderna Sues Pfizer Over Patents Behind COVID-19 Vaccine
Written by TOM MURPHY COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, […]
Heart Reaction Probed as Possible Rare Vaccine Link in Teens
Written by LINDSEY TANNER and LAURAN NEERGAARD Health authorities are trying to determine whether heart inflammation that can occur along with many types of infections could also be a rare side effect in teens and young adults after the second dose of COVID-19 vaccine. An article on seven U.S. teen boys in several states, published online […]
Pfizer COVID-19 Shot Expanded to U.S. Children as Young as 12
Written by LAURAN NEERGAARD and CANDICE CHOI U.S. regulators on Monday expanded the use of Pfizer’s COVID-19 vaccine to children as young as 12, offering a way to protect the nation’s adolescents before they head back to school in the fall and paving the way for them to return to more normal activities. Shots could begin […]
U.S. Drop In Vaccine Demand Has Some Places Turning Down Doses
Written by LEAH WILLINGHAM, HEATHER HOLLINGSWORTH and MICHELLE R. SMITH Louisiana has stopped asking the federal government for its full allotment of COVID-19 vaccine. About three-quarters of Kansas counties have turned down new shipments of the vaccine at least once over the past month. And in Mississippi, officials asked the federal government to ship vials in […]
Tactical Shift: Europe Seeks Vaccine ‘Overdrive’ To Catch Up
Written by FRANK JORDANS Slow off the blocks in the race to immunize its citizens against COVID-19, Germany faces an unfamiliar problem: a glut of vaccines and not enough arms to inject them into. Like other countries in the European Union, its national vaccine campaign lags far behind that of Israel, Britain and the United […]
U.S. Boosting Vaccine Deliveries Amid Complaints of Shortages
Answering growing frustration over vaccine shortages, President Joe Biden announced that the U.S. is ramping up deliveries to hard-pressed states over the next three weeks and expects to provide enough doses to vaccinate 300 million Americans by the end of the summer or early fall. Biden, calling the push a “wartime effort,” said Tuesday the […]
US Clears Updated COVID Boosters Targeting Newest Variants
Written by LAURAN NEERGAARD The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope […]
National Expert: Getting Kids Vaccinated Before School is 'Best Thing to Do'
Younger children are the age demographic that had the longest waits for COVID-19 vaccines to be approved. So far, their vaccination rates reflect that gap of time, but urgency around getting those initial doses has slowed to a crawl. With a new school year being just around the corner, though, federal health officials are saying […]
Shots for Tots: NC Begins COVID-19 Vaccines for Young Children
The Centers for Disease Control recently approved both Moderna and Pfizer vaccines for children as young as six months. Locally, Orange County vaccines for the young age group are available starting Monday and by appointment only at the Southern Human Services Center in Chapel Hill.
Marathon US Hearings To Decide Fate of COVID Shots for Tots
Written by LAURAN NEERGAARD Parents anxious to finally vaccinate their youngest children against COVID-19, strap in: A lot is set to happen over the next week. On Wednesday, both Moderna and Pfizer will have to convince what’s essentially a science court — advisers to the Food and Drug Administration — that their shots work well in babies, toddlers and […]
›